Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Curr Med Imaging ; 19(9): 995-1004, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37264634

RESUMO

OBJECTIVE: The objective of the paper was to compare the value of CT and MRI in the diagnosis of primary carcinoma of the liver. METHODS: A retrospective analysis was performed on 132 cases of suspected primary liver carcinoma. CT and MRI diagnosis were performed and pathological results were compared to determine the diagnostic value of the two methods. RESULTS: 96 cases were diagnosed as primary liver carcinoma by pathological examination after operation. The total detection rate of 96 lesions through MRI was 93.75%, while 84.38% through CT (P<0.05). For lesions with a <3 cm diameter, the CT detection rates of lesions in the plain, arterial, portal, and equilibrium phases were 52.94%, 73.53%, 58.82%, and 58.82% respectively. For lesions with a diameter ≥ 3 cm, the CT detection rate was 80.65 %, 93.55%, 85.48%, and 83.87%, respectively (P<0.05). For lesions with <3cm diameter, the MRI detection rates of lesions in the T1WI, T2WI, LAVA arterial phase, LAVA portal phase, and LAVA balance phase were 61.76%, 76.47%, 88.24%, 79.41%, and 52.94%, respectively, and for lesions with ≥3cm diameter, the detection rates of MRI were 77.42%, 87.10%, 91.94%, 90.32%, and 90.32%, respectively, and the detection rate of lesions with ≥3cm diameter in the balance phase of LAVA was higher (P<0.05). Taking pathological results as the gold standard, the sensitivity of diagnosing primary liver carcinoma through CT is 81.25%, specificity is 75.00%, accuracy is 79.55%, the positive predictive value is 89.66%, the negative predictive value is 60.00%, and the values of the same parameters for the MRI are 93.75. %, 86.11%, 91.67%, 94.74%, and 83.78% respectively. CONCLUSION: Both CT and MRI have diagnostic value for primary liver carcinoma. The comparison showed that MRI has a higher diagnostic value and higher detection rate for small lesions. However, the actual process of diagnosis cannot rely solely on MRI, and a comprehensive combination of diagnosis methods will be effective.


Assuntos
Carcinoma Hepatocelular , Neoplasias Hepáticas , Humanos , Carcinoma Hepatocelular/diagnóstico por imagem , Estudos Retrospectivos , Neoplasias Hepáticas/diagnóstico por imagem , Tomografia Computadorizada por Raios X/métodos , Imageamento por Ressonância Magnética/métodos
2.
J Surg Res ; 272: 69-78, 2022 04.
Artigo em Inglês | MEDLINE | ID: mdl-34936914

RESUMO

BACKGROUND: In the 2016 ISHLT listing criteria guidelines for heart transplantation, recipients were recommended to have a body mass index (BMI) <35 kg/m². However, outcomes data for subgroups of transplant recipients with a BMI >35 kg/m² are limited. We examined the outcomes of heart transplant recipients who had a BMI of 35 to 39.9 kg/m² or ≥40 kg/m² and compared their outcomes with recipients who had a BMI <35 kg/m2. METHODS: Using data from the United Network for Organ Sharing database, we performed a retrospective cohort analysis of 23,009 adults who underwent cardiac transplantation between 2009 and 2018. Transplant recipients were stratified by BMI categories (<35 kg/m², 35-39.9 kg/m², and ≥40 kg/m²). Patient survival was depicted by Kaplan-Meier curves. Cox proportional-hazards modeling was used to determine the prognostic factors associated with mortality within 90 days, 1 year, and 5 years after transplantation. RESULTS: Survival at 90 days, 1 year, and 5 years after transplantation was better in recipients who had a BMI <35 kg/m² than in those who had a BMI of 35 to 39.9 kg/m² (P values ranged from 0.01 to < 0.001) or ≥40 kg/m² (P < 0.001). Additionally, survival at 90 days (P < 0.001) and 1 year (P = 0.002) was significantly better in recipients who had a BMI of 35 to 39.9 kg/m² than in those who had a BMI ≥40 kg/m². In multivariate analysis, a BMI of 35 to 39.9 was significantly associated with increased 90-day mortality (HR = 1.53; 95% CI 1.12, 2.08; P = 0.01) but not increased 1-year (HR = 1.28; 95% CI 0.99, 1.66; P = 0.06) or 5-year mortality (HR = 1.11; 95% CI 0.91, 1.36; P = 0.29). CONCLUSIONS: Although heart transplant recipients with class II obesity (BMI 35-39.9 kg/m²) may have suboptimal survival compared with those who have a BMI <35 kg/m², these patients have better outcomes than do those with class III obesity (BMI ≥40 kg/m²). Thus, contrary to current guidelines, selected patients with class II obesity should be considered for transplantation.


Assuntos
Transplante de Coração , Obesidade , Adulto , Índice de Massa Corporal , Humanos , Obesidade/complicações , Obesidade/cirurgia , Modelos de Riscos Proporcionais , Estudos Retrospectivos , Transplantados , Resultado do Tratamento
5.
Biomed Res Int ; 2020: 3178037, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33015161

RESUMO

Osteosarcoma is a highly malignant bone cancer which primarily occurs in children and young adults. Increasing evidence indicates that long noncoding RNAs (lncRNAs), which function as competing endogenous RNAs (ceRNAs) that sponge microRNAs (miRNAs) and messenger RNAs (mRNAs), play a pivotal role in the pathogenesis and progression of cancers. The regulatory mechanisms of lncRNA-mediated ceRNAs in osteosarcoma have not been fully elucidated. In this study, we identified differentially expressed lncRNAs, miRNAs, and mRNAs in osteosarcoma based on RNA microarray profiles in the Gene Expression Omnibus (GEO) database. A ceRNA network was constructed utilizing bioinformatic tools. Kaplan-Meier survival analysis showed that lncR-C3orf35 and HMGB1 were associated with poor prognosis of osteosarcoma patients. Furthermore, results of Gene Set Enrichment Analysis (GSEA) suggested that lncR-C3orf35 may be involved in cellular invasion, the Toll-like receptor signaling pathway, and immune cell infiltration in the tumor microenvironment. Further analysis showed that patients with osteosarcoma metastasis expressed higher levels of lncR-C3orf35 and HMGB1 compared to metastasis-free patients. Moreover, the metastasis-free survival rate of the high lncR-C3orf35/HMGB1 expression group was significantly lower than that of the low expression group. The ESTIMATE algorithm was used to calculate the immune score and stromal scores for each sample. High lncR-C3orf35 and HMGB1 levels were correlated with low immune scores. ImmuCellAI analysis revealed that a low proportion of macrophage infiltration was associated with high lncR-C3orf35 and HMGB1 expression. The differential expression of lncR-C3orf35, miR-142-3p, and HMGB1 was further verified by quantitative real-time PCR. This study indicates that lncR-C3orf35 could be considered as a novel potential biomarker and therapeutic target of osteosarcoma, which may contribute to a better understanding of ceRNA regulatory mechanisms.


Assuntos
Regulação Neoplásica da Expressão Gênica/genética , Redes Reguladoras de Genes/genética , Osteossarcoma/genética , Osteossarcoma/patologia , RNA Longo não Codificante/genética , Adolescente , Adulto , Biomarcadores Tumorais/genética , Criança , Feminino , Perfilação da Expressão Gênica/métodos , Ontologia Genética , Humanos , Estimativa de Kaplan-Meier , Masculino , Análise em Microsséries/métodos , Osteossarcoma/mortalidade , Prognóstico , Taxa de Sobrevida , Microambiente Tumoral/imunologia , Adulto Jovem
6.
J Cell Biochem ; 121(7): 3479-3490, 2020 07.
Artigo em Inglês | MEDLINE | ID: mdl-31898371

RESUMO

Osteosarcoma (OS) is the most common primary solid malignant bone tumor, and its metastasis is a prominent cause of high mortality in patients. In this study, a prognosis risk signature was constructed based on metastasis-associated genes. Four microarrays datasets with clinical information were downloaded from Gene Expression Omnibus, and 256 metastasis-associated genes were identified by limma package. Further, a protein-protein interaction network was constructed, and survival analysis was performed using data from the Therapeutically Applicable Research to Generate Effective Treatments data matrix, identifying 19 genes correlated with prognosis. Six genes were selected by the least absolute shrinkage and selection operator regression for multivariate cox analysis. Finally, a three-gene (MYC, CPE, and LY86) risk signature was constructed, and datasets GSE21257 and GSE16091 were used to validate the prediction efficiency of the signature. The survival times of low- and high-risk groups were significantly different in the training set and validation set. Additionally, gene set enrichment analysis revealed that the genes in the signature may affect the cell cycle, gap junctions, and interleukin-6 production. Therefore, the three-gene survival risk signature could potentially predict the prognosis of patients with OS. Further, proteins encoded by CPE and LY86 may provide novel insights into the prediction of OS prognosis and therapeutic targets.


Assuntos
Neoplasias Ósseas/mortalidade , Neoplasias Ósseas/patologia , Osteossarcoma/mortalidade , Osteossarcoma/patologia , Neoplasias Ósseas/diagnóstico , Perfilação da Expressão Gênica , Regulação Neoplásica da Expressão Gênica , Humanos , Estimativa de Kaplan-Meier , Análise Multivariada , Metástase Neoplásica , Nomogramas , Análise de Sequência com Séries de Oligonucleotídeos , Osteossarcoma/diagnóstico , Prognóstico , Mapeamento de Interação de Proteínas , Curva ROC , Análise de Regressão , Risco , Medição de Risco , Fatores de Risco , Resultado do Tratamento
7.
Artigo em Inglês | MEDLINE | ID: mdl-31511778

RESUMO

Joint contracture is increasingly regarded as a clinical problem that leads to irreversible dysfunction of the joint. It is a pathophysiological process following joint injury, which is marked by the activation of myofibroblasts. There is currently no effective treatment for the prevention of joint contracture. Curcumin is a polyphenol pigment extracted from turmeric, which possesses anti-inflammatory, antioxidative, and antitumor properties. In the present study, we demonstrated that curcumin exerts a protective effect against joint contracture via the inhibition of myofibroblast proliferation and migration in a time- and concentration-dependent manner. Moreover, we indicated that phosphatase and tension homolog (PTEN) was downregulated in myofibroblasts in vitro and in the contracture capsule tissues of patients in vivo. Additionally, western blot analysis revealed a negative correlation between the expression levels of PTEN and the fibrosis marker protein alpha smooth muscle cell actin. Methylation-specific PCR results suggested that curcumin was able to demethylate PTEN in a similar manner to the demethylation agent 5-azacytidine, increasing PTEN expression and further inhibiting phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin signaling. In conclusion, our data illustrate part of the mechanism of curcumin inhibition in joint contracture. These results support the hypothesis that curcumin may potentially be used as a novel candidate for the treatment of joint contracture.

8.
J Vis Exp ; (147)2019 05 20.
Artigo em Inglês | MEDLINE | ID: mdl-31157767

RESUMO

Joint contracture, resulting from a prolonged joint immobilization, is a common complication in orthopedics. Currently, utilizing an internal fixation to restrict knee joint mobility is a widely accepted model to generate experimental contracture. However, implanting application will inevitably cause surgical trauma to the animals. Aiming to develop a less invasive approach, we combined a muscle-gap separation modus with a previously reported mini-incision skill during the surgical procedure: Two mini skin incisions were made on the lateral thigh and leg, followed by performing muscle-gap separation to expose the bone surface. The rat knee joint was gradually immobilized by a preconstructed internal fixation at approximately 135° knee flexion without interfering essential nerves or blood vessels. As expected, this simple technique permits rapid postoperative rehabilitation in animals. The correct position of the internal fixation was confirmed by an x-ray or micro-CT scanning analysis. The range of motion was significantly restricted in the immobilized knee joint than that observed in the contralateral knee joint demonstrating the effectiveness of this model. Besides, histological analysis revealed the development of fibrous deposition and adhesion in the posterior-superior knee joint capsule over time. Thus, this mini-invasive model may be suitable for mimicking the development of immobilized knee joint contracture.


Assuntos
Contratura/fisiopatologia , Imobilização/métodos , Articulação do Joelho/fisiopatologia , Animais , Contratura/patologia , Modelos Animais de Doenças , Fibrose , Cápsula Articular/patologia , Articulação do Joelho/patologia , Masculino , Amplitude de Movimento Articular , Ratos , Aderências Teciduais
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...